Related Experiment Video
Updated: May 15, 2026
08:33
A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
When the FRAX(®) test is applied to controlled clinical trials
Carmelo Erio Fiore1, Agostino Gaudio
1School of Medicine, Department of Internal Medicine, University of Catania, Italy.
Summary
The FRAX(®) tool assesses fracture risk using clinical factors. Recent studies evaluate osteoporosis drug effectiveness in women with higher FRAX(®) scores.
Area of Science:
- Osteoporosis research
- Biostatistics
- Pharmacoeconomics
Background:
- The FRAX(®) tool estimates 10-year fracture probability using clinical risk factors.
- It aids in assessing osteoporosis risk in men and women.
- Bone mineral density can optionally enhance FRAX(®) predictions.
Purpose of the Study:
- To re-evaluate the effectiveness of postmenopausal osteoporosis drugs.
- To determine if drug efficacy varies with FRAX(®) fracture probability scores.
Main Methods:
- Utilized the FRAX(®) computer-based algorithm.
- Included clinical risk factors: age, BMI, prior fracture, parental hip fracture history, smoking, glucocorticoid use, rheumatoid arthritis, secondary osteoporosis, and alcohol consumption.
- Optionally incorporated femoral neck bone mineral density.
Main Results:
- FRAX(®) outputs 10-year probabilities for major osteoporotic and hip fractures.
- Studies investigated drug effectiveness based on FRAX(®) probability stratification.
- Findings may indicate differential drug efficacy in higher-risk populations.
Conclusions:
- FRAX(®) is a valuable tool for fracture risk assessment.
- Further research is needed to confirm if osteoporosis drug effectiveness is stratified by FRAX(®) scores.
- This approach could personalize osteoporosis treatment strategies.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:14Identifying Statistically Significant Differences: The F-Test
The F-test is used to compare two sample variances to each other or compare the sample variance to the population variance. It is used to decide whether an indeterminate error can explain the difference in their values. The underlying assumptions that allow the use of the F-test include the data set or sets are normally distributed, and the data sets are independent of each other. The test statistic F is calculated by dividing one variance by another. In other words, the square of one standard...